Does Rallies show Form 4 insider transactions for PLRX?

Yes. Rallies tracks PLRX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is PLRX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PLRX. It does not provide personalized investment advice.

PLRX (Pliant Therapeutics, Inc. Common Stock) Stock Analysis - Insider Trades

Pliant Therapeutics, Inc. Common Stock (PLRX) is a publicly traded Healthcare sector company. As of May 21, 2026, PLRX trades at $1.19 with a market cap of $73.07M and a P/E ratio of -0.50. PLRX moved +5.22% today. Year to date, PLRX is -6.61%; over the trailing twelve months it is -12.41%. Its 52-week range spans $1.09 to $16.10. Analyst consensus is neutral with an average price target of $2.67. Rallies surfaces PLRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PLRX stock inside the company?

Recent PLRX insider activity includes Cummings Keith Lamont sold 24.00K, Cheung Lily sold 7.53K, Coulie Bernard sold 89.38K, Kuo Minnie sold 6.92K, and Ouimette Mike sold 10.23K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

PLRX Key Metrics

Key financial metrics for PLRX
Metric	Value
Price	$1.19
Market Cap	$73.07M
P/E Ratio	-0.50
EPS	$-2.43
Dividend Yield	0.00%
52-Week High	$16.10
52-Week Low	$1.09
Volume	906
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-149.34M
Gross Margin	0.00%

Recent PLRX Insider Trades

Cummings Keith Lamont sold 24.00K (~$30.72K) on Jan 20, 2026.
Cheung Lily sold 7.53K (~$9.64K) on Jan 20, 2026.
Coulie Bernard sold 89.38K (~$114.40K) on Jan 20, 2026.
Kuo Minnie sold 6.92K (~$8.85K) on Jan 20, 2026.
Ouimette Mike sold 10.23K (~$112.46K) on Jan 22, 2025.

Latest PLRX News

Pliant Therapeutics Posts 4 Responders with 71% Tumor Reduction, Q2 Phase Ib Planned — Mar 1, 2026

PLRX Analyst Consensus

5 analysts cover PLRX: 0 strong buy, 1 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.67.

Common questions about PLRX

Who is trading PLRX stock inside the company?: Recent PLRX insider activity includes Cummings Keith Lamont sold 24.00K, Cheung Lily sold 7.53K, Coulie Bernard sold 89.38K, Kuo Minnie sold 6.92K, and Ouimette Mike sold 10.23K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PLRX?: Yes. Rallies tracks PLRX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PLRX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PLRX. It does not provide personalized investment advice.